FeesSafety
Pluang+

VolitionRx joins France's DETECSEPS project to advance early sepsis detection.

Market News
17 Sep 2026
PRNewsWire
View Source
Bullish
VolitionRx joins France's DETECSEPS project to advance early sepsis detection.

VolitionRx Limited, a multinational epigenetics company, has announced its participation in the official launch of the DETECSEPS Consortium in France. This government-funded project focuses on the early detection of sepsis, a critical and life-threatening condition. The initiative aligns with VolitionRx's mission to improve diagnosis and monitoring of serious diseases. This collaboration could lead to significant advancements in sepsis detection and patient outcomes.

VolitionRx's DETECSEPS program launch in France is presented here with Pluang's Health-sector market data as of Sep 17, 2026 19:42 WIB. Among 91 priced Health-sector US stocks tradable on Pluang, 74 rose and 15 fell today. Notable movers include ABCL at USD 12.07 with a 1-day change of +3.43% and Pluang order activity heavily skewed to 99% Sell, ASND at USD 239.50 down 3.31% with 91% Sell activity, and SANA at USD 3.01 up 3.08% with 86% Sell activity. The typical hold time on Pluang ranges from 22 to 55 days for these stocks.

More News

Palantir projects $2.16B revenue for Q3, with recent quarters hinting even stronger results ahead.

Palantir projects $2.16B revenue for Q3, with recent quarters hinting even stronger results ahead.

Palantir has guided its revenue for the third quarter of 2026 to reach $2.16 billion. This forecast is supported by the company's performance in the last two quarters, which suggests that actual results could surpass expectations. The strong revenue ...

Company Fundamentals
Bullish
1 hour ago
Evernorth highlights 13-year-old XRP wallet with limited merchandise and community event.

Evernorth highlights 13-year-old XRP wallet with limited merchandise and community event.

Evernorth Holdings, a Nasdaq-listed company managing a large XRP treasury, is collaborating with the Fuzzies community to release limited merchandise celebrating the historic Fuzzybear wallet activated in 2013. This initiative honors early XRP suppor...

Market News
Bullish
4 hours ago
Budoprutug shows promising early results in treating primary membranous nephropathy with good tolerance.

Budoprutug shows promising early results in treating primary membranous nephropathy with good tolerance.

Climb Bio presented Phase 2 data for budoprutug, an anti-CD19 antibody, showing effective B-cell depletion and reduction of PLA2R antibodies in primary membranous nephropathy (pMN) patients at 12 weeks. The 200 mg dose demonstrated immunologic remiss...

Company Fundamentals
Bullish
4 hours ago
Hyperliquid (HYPE) struggles to reach $90 target amid supply growth and recent price drop.

Hyperliquid (HYPE) struggles to reach $90 target amid supply growth and recent price drop.

Hyperliquid (HYPE) is currently priced around $76, needing a 19.2% rise to hit the $90 target set by many holders. Despite a strong 107% gain over 200 days, HYPE has fallen 17.1% in the last month, pressured by a growing unlocked token supply and a r...

Market News
Neutral
4 hours ago
Quebec's maple syrup reserve to run out by February, reducing buffer for production changes.

Quebec's maple syrup reserve to run out by February, reducing buffer for production changes.

Quebec's maple syrup reserve, stored in warehouses with a capacity of about 218,000 barrels, is expected to be depleted by February. This reserve helps balance supply fluctuations caused by weather, which strongly affects syrup production. Canadian s...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App